Figure 3.
Cumulative incidence estimates of malignancy-associated bowel obstruction readmission and end-of-life outcomes based upon treatment for malignancy-associated bowel obstruction
Cumulative incidence estimates of malignancy-associated bowel obstruction readmission and end-of-life outcomes based upon treatment for malignancy-associated bowel obstruction